Ocuphire Pharma Results

Ocuphire APX3330 KOL Event: Agenda & Speakers Ocuphire Speakers Mina Sooch, MBA President & CEO and Founder Ocuphire Caroline Baumal, MD Tufts Medical Peter Kaiser, MD Cleveland Clinic Cole Eye Institute David Lally, MD NEW ENGLAND RETINA CONSULTANTS Caroline Baumal, MD Tufts Medical Agenda Introductions & Company Overview Disease of Diabetic Retinopathy Current DR/DME Treatment Landscape APX3330, Paradigm-Shifting Oral Treatment Option ZETA-1, Phase 2b Trial in Diabetic Retinopathy and Masked Safety Data Time (EDT) 11:00 am - 11:10 am 11:10 am - 11:20 am 11:20 am - 11:35 am 11:35 am - 11:50 am 11:50 am - 12:00 pm 3

View entire presentation